BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 9120000)

  • 1. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
    Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
    J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.
    Liekens S; Leali D; Neyts J; Esnouf R; Rusnati M; Dell'Era P; Maudgal PC; De Clercq E; Presta M
    Mol Pharmacol; 1999 Jul; 56(1):204-13. PubMed ID: 10385702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity to glomerular mesangial cells and receptor binding of a heparin-mimicking polyaromatic anionic compound.
    Katz A; Vlodavsky I; Davies M; Miao HQ; Ben-Sasson SA; Darmon D; Hurwitz H; Borgel H; Benezra M
    J Am Soc Nephrol; 1997 Nov; 8(11):1688-97. PubMed ID: 9355071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells.
    Richard C; Liuzzo JP; Moscatelli D
    J Biol Chem; 1995 Oct; 270(41):24188-96. PubMed ID: 7592623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.
    Medalion B; Merin G; Aingorn H; Miao HQ; Nagler A; Elami A; Ishai-Michaeli R; Vlodavsky I
    Circulation; 1997 Apr; 95(7):1853-62. PubMed ID: 9107173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound.
    Schmidt A; Vlodavsky I; Völker W; Buddecke E
    Atherosclerosis; 1999 Dec; 147(2):387-97. PubMed ID: 10559525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin.
    Lundin L; Rönnstrand L; Cross M; Hellberg C; Lindahl U; Claesson-Welsh L
    Exp Cell Res; 2003 Jul; 287(1):190-8. PubMed ID: 12799194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds.
    Benezra M; Ben-Sasson SA; Regan J; Chang M; Bar-Shavit R; Vlodavsky I
    Arterioscler Thromb; 1994 Dec; 14(12):1992-9. PubMed ID: 7981190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2.
    Hagedorn M; Zilberberg L; Lozano RM; Cuevas P; Canron X; Redondo-Horcajo M; Gimenez-Gallego G; Bikfalvi A
    FASEB J; 2001 Mar; 15(3):550-2. PubMed ID: 11259363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A.
    Motamed K; Blake DJ; Angello JC; Allen BL; Rapraeger AC; Hauschka SD; Sage EH
    J Cell Biochem; 2003 Oct; 90(2):408-23. PubMed ID: 14505356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
    Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
    Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
    Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
    J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
    Moscatelli D
    J Biol Chem; 1992 Dec; 267(36):25803-9. PubMed ID: 1464594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
    Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
    Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.